Resdevco


Resdevco is a pharmaceutical research company focused on developing formulations that modulate gene expression to restore tissue protein balance. The organization pursues topical and mucosal therapeutics (eye, skin, nasal, gastrointestinal and intimate applications), advances preclinical and clinical testing programs, maintains an intellectual property portfolio, and prepares regulatory and manufacturing documentation to support product registration and scale-up.

Industries

Health Care
Pharmaceutical
Biotechnology Research

Nr. of Employees

small (1-50)


Patents

Eye drops for treatment of irritation not due to infection

US-11426361-B2

View Details

Eye drops for treatment of irritation not due to infection

US-11033513-B2

View Details

Eye drops for treatment of conjunctivochalasis

US-8912166-B2

View Details

Products

Preservative-free nasal spray for dry nasal mucosa

A broad-spectrum nasal formulation designed to reactivate damaged nasal mucosal tissue, reduce inflammation, improve mucociliary function, and lower risk of secondary bacterial colonization.

Unit-dose moisturizing ophthalmic drops

Single-use ophthalmic drops intended to treat various dry eye conditions, including Sjögren syndrome dry eye and conjunctivochalasis, by decreasing inflammatory marker production and restoring tear film stability.

Viscous non-Newtonian moisturizing gel for dry and irritated skin

A viscous moisturizing gel for treatment of dry, flaky and irritated skin, intended for broad use including atopic dermatitis and hand eczema; includes glycerol and xylitol to improve barrier function.

Preservative-free moisturizing gel for dry skin

A preservative- and paraben-free moisturizing gel formulated for dehydrated skin to hydrate, smooth and protect the skin surface and restore protective function.

Hormone-free topical gel for vaginal dryness and intimate tissue repair

A non-hormonal, non-steroidal gel intended to relieve vaginal dryness and restore local tissue lubrication and integrity, formulated for populations where hormones are contraindicated.

Expertise Areas

  • Gene expression modulation therapeutics
  • Topical and mucosal formulation development
  • Preclinical in vitro and animal model testing
  • Clinical trial management for small-scale studies
  • Show More (6)

Key Technologies

  • Gene expression modulation (mRNA-level regulation)
  • Endogenous bioactive molecule therapeutics
  • Preservative-free non-Newtonian gel formulations
  • Unit-dose ophthalmic delivery systems
  • Show More (5)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.